Notably, HAART-treated children had higher frequencies of memory B cells against measles Ag and pneumococcal capsular polysaccharides than the HAART-naive children within the low-viremia group (p = 0.0046 and 0.0162, respectively), probably because HAART-naive children were younger and had received less environmental exposure. Here, RENBP is linked to measles.